
Article 1 
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 16 October 2020.
For the Commission
The President
Ursula VON DER LEYEN
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2021’;
((2)) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2021’;
((3)) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2021’;
((4)) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2021’;
((5)) in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2021’;
((6)) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2021’;
((7)) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2021’;
((8)) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2021’;
((9)) in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2021’;
((10)) in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2021’;
((11)) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2021’;
((12)) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2021’;
((13)) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2021’;
((14)) in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2021’;
((15)) in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2021’;
((16)) in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2021’;
((17)) in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2021’;
((18)) in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2021’;
((19)) in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2021’;
((20)) in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2021’;
((21)) in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2021’;
((22)) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2021’;
((23)) in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2021’;
((24)) in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2021’;
((25)) in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2021’;
((26)) in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2021’;
((27)) in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2021’.
